GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,858,994 shares; 2025Q1: 6,443,940 shares; 2025Q2: 6,746,951 shares; 2025Q3: 8,601,189 shares; 2025Q4: 10,406,575 shares; 2026Q1: 10,763,288 shares; 2026Q2: 13,263,288 shares; 2026Q3: 13,263,288 shares 13,263,288 $311M 48.2% 0 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,257,795 shares; 2025Q1: 3,215,722 shares; 2025Q2: 4,400,842 shares; 2025Q3: 5,766,090 shares; 2025Q4: 8,963,500 shares; 2026Q1: 8,963,500 shares; 2026Q2: 8,963,500 shares; 2026Q3: 8,963,500 shares 8,963,500 $138M 21.3% 0 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,187,191 shares; 2025Q1: 5,291,929 shares; 2025Q2: 5,404,674 shares; 2025Q3: 5,404,674 shares; 2025Q4: 5,404,674 shares; 2026Q1: 4,763,673 shares; 2026Q2: 4,038,404 shares; 2026Q3: 3,896,169 shares 3,896,169 $101M 15.68% -142,235 Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,852,744 shares; 2025Q1: 7,098,133 shares; 2025Q2: 7,098,133 shares; 2025Q3: 7,098,133 shares; 2025Q4: 7,098,133 shares; 2026Q1: 6,998,902 shares; 2026Q2: 7,326,691 shares; 2026Q3: 7,530,915 shares 7,530,915 $25.1M 3.88% +204,224 Timeline DTIL PRECISION BIOSCIENCES INC More: the full row for PRECISION BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 766,051 shares; 2025Q1: 766,051 shares; 2025Q2: 1,036,051 shares; 2025Q3: 1,042,596 shares; 2025Q4: 993,913 shares; 2026Q1: 985,113 shares; 2026Q2: 950,466 shares; 2026Q3: 2,758,215 shares 2,758,215 $17.3M 2.67% +1,807,749 Timeline AGIO AGIOS PHARMACEUTICALS INC More: the full row for AGIOS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 79,624 shares; 2026Q1: 2,611,568 shares; 2026Q2: 3,408,937 shares; 2026Q3: 472,606 shares 472,606 $15.7M 2.43% -2,936,331 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 677,915 shares; 2026Q1: 1,538,296 shares; 2026Q2: 1,538,296 shares; 2026Q3: 1,544,980 shares 1,544,980 $15.3M 2.37% +6,684 2026-10-26, Form 4 : bought 25,124 shares on 2026-10-26 Timeline NEUP NEUPHORIA THERAPEUTICS INC More: the full row for NEUPHORIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 45,806 shares; 2025Q1: 45,806 shares; 2025Q2: 45,806 shares; 2025Q3: not reported; 2025Q4: 875,228 shares; 2026Q1: 875,328 shares; 2026Q2: 875,328 shares; 2026Q3: 875,328 shares 875,328 $3.12M 0.48% 0 Timeline PASG PASSAGE BIO INC More: the full row for PASSAGE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 623,704 shares; 2025Q4: 623,704 shares; 2026Q1: 623,704 shares; 2026Q2: 673,759 shares; 2026Q3: 673,759 shares 673,759 $3.03M 0.47% 0 Timeline PRQR PROQR THRAPEUTICS N V More: the full row for PROQR THRAPEUTICS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 68,486 shares; 2026Q1: 68,486 shares; 2026Q2: 521,413 shares; 2026Q3: 1,562,093 shares 1,562,093 $2.59M 0.4% +1,040,680 Timeline TCRX TSCAN THERAPEUTICS INC More: the full row for TSCAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,357,347 shares; 2025Q1: 5,357,347 shares; 2025Q2: 7,857,347 shares; 2025Q3: 7,857,347 shares; 2025Q4: 8,019,148 shares; 2026Q1: 8,019,148 shares; 2026Q2: 8,019,148 shares; 2026Q3: 8,019,148 shares 8,019,148 $2.52M 0.39% 0 Timeline KZIA KAZIA THERAPEUTICS LTD More: the full row for KAZIA THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,800 shares 225,800 $2.17M 0.34% new Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,798,070 shares; 2026Q3: 1,798,070 shares 1,798,070 $1.94M 0.3% 0 Timeline TRDA ENTRADA THERAPEUTICS INC More: the full row for ENTRADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 51,689 shares; 2026Q1: 211,689 shares; 2026Q2: 178,606 shares; 2026Q3: 278,606 shares 278,606 $1.77M 0.27% +100,000 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $644K 0.1% new Timeline IMTX IMMATICS N.V More: the full row for IMMATICS N.V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 921,950 shares; 2026Q1: 216,973 shares; 2026Q2: 23,236 shares; 2026Q3: 71,263 shares 71,263 $626K 0.1% +48,027 Timeline HOWL WEREWOLF THERAPEUTICS INC More: the full row for WEREWOLF THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 655,926 shares; 2026Q1: 657,786 shares; 2026Q2: 657,786 shares; 2026Q3: 657,786 shares 657,786 $607K 0.09% 0 Timeline YARW YARROW BIOSCIENCE INC More: the full row for YARROW BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 22,000 shares 22,000 $495K 0.08% new Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 705,558 shares; 2026Q1: 536,398 shares; 2026Q2: 18,194 shares; 2026Q3: 18,194 shares 18,194 $454K 0.07% 0 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 14,300 shares 14,300 $433K 0.07% new Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,000 shares 25,000 $403K 0.06% new Timeline TRAW TRAWS PHARMA INC More: the full row for TRAWS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 15,078 shares; 2026Q2: 559,470 shares; 2026Q3: 559,470 shares 559,470 $332K 0.05% 0 Timeline DNLI DENALI THERAPEUTICS INC More: the full row for DENALI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 261,687 shares; 2025Q4: 1,738,750 shares; 2026Q1: 1,880,303 shares; 2026Q2: 11,658 shares; 2026Q3: 11,658 shares 11,658 $241K 0.04% 0 Timeline ABSI ABSCI CORPORATION More: the full row for ABSCI CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 21,245 shares; 2026Q2: 21,245 shares; 2026Q3: 21,245 shares 21,245 $229K 0.04% 0 Timeline FHTX FOGHORN THERAPEUTICS INC More: the full row for FOGHORN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 61,588 shares; 2026Q3: 61,588 shares 61,588 $220K 0.03% 0 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,100 shares; 2026Q3: 10,100 shares 10,100 $155K 0.02% 0 Timeline PRME PRIME MEDICINE INC More: the full row for PRIME MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 45,000 shares 45,000 $137K 0.02% new Timeline BOLT BOLT BIOTHERAPEUTICS INC More: the full row for BOLT BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 30,800 shares; 2026Q2: 30,800 shares; 2026Q3: 30,800 shares 30,800 $113K 0.02% 0 Timeline EPRX EUPRAXIA PHARMACEUTICALS INC More: the full row for EUPRAXIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000 $91K 0.01% 0 Timeline NUVB NUVATION BIO INC More: the full row for NUVATION BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,029 shares; 2026Q3: 16,029 shares 16,029 $89.8K 0.01% 0 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000 $1.2K <0.01% 0 Timeline